Literature DB >> 6407791

Intrathecal antibody synthesis to virus antigens in multiple sclerosis.

A Salmi, M Reunanen, J Ilonen, M Panelius.   

Abstract

Intrathecal antibody synthesis against 17 common viruses and Mycoplasma pneumoniae lipid antigen was measured in 30 multiple sclerosis patients and 30 patients with other neurological diseases. Antibody synthesis was found against all of the antigens in at least a few of the MS patients. The highest number of patients had intrathecal synthesis of antibodies to measles, rubella and paramyxo type viruses and the lowest frequency was against M. pneumoniae, herpes simplex virus, adenovirus and cytomegalovirus antigens. Simultaneous antibody synthesis occurred against 1-11 different antigens in these patients. When the summation of different antibody specificities synthesized intrathecally was compared to the CSF-IgG Index, which measures the intrathecal immunoglobulin G synthesis, a fairly close correlation was found. The control patients had occasional antibody synthesis but generally only against one single virus antigen. The intrathecal antibody synthesis against viruses did not correlate to the disability of the MS patients. The intrathecal antibody synthesis was not different in younger and older patients or patients with shorter or longer disease duration, suggesting that events leading to intrathecal antibody synthesis may occur relatively early in life in these patients. When presence of Dw2 antigen was compared to different specificities of intrathecally synthesized immunoglobulins, only measles virus antibody synthesis showed correlation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407791      PMCID: PMC1535858     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Lethality, duration, and mortality of disseminated sclerosis in Denmark.

Authors:  K Hyllested
Journal:  Acta Psychiatr Scand       Date:  1961       Impact factor: 6.392

3.  Multiple sclerosis: local synthesis of electrophoretically restricted measles, rubella, mumps and herpes simplex virus antibodies in the central nervous system.

Authors:  H J Nordal; B Vandvik; E Norrby
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Specific in vitro antibody response to varicella zoster.

Authors:  R L Souhami; J Babbage; R E Callard
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

6.  Viral and bacterial antibody responses in multiple sclerosis.

Authors:  F Vartdal; B Vandvik; E Norrby
Journal:  Ann Neurol       Date:  1980-09       Impact factor: 10.422

7.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

8.  Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis.

Authors:  A A Salmi; E Norrby; M Panelius
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

9.  Involvement of the central nervous system in acute, uncomplicated measles virus infection.

Authors:  P Hänninen; P Arstila; H Lang; A Salmi; M Panelius
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

10.  Poliomyelitis: immunoglobulin-containing cells in the central nervous system in acute and convalescent phases of the human disease.

Authors:  M M Esiri
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

View more
  22 in total

1.  Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

Authors:  J Lycke; B Svennerholm; E Hjelmquist; L Frisén; G Badr; M Andersson; A Vahlne; O Andersen
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

2.  Immunological differentiation between neuroborreliosis and multiple sclerosis.

Authors:  J Heller; G Holzer; K Schimrigk
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

Review 3.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  Cells producing antibody to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls.

Authors:  S Baig; O Olsson; T Olsson; A Löve; S Jeansson; H Link
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

5.  Immunoglobulin G subclass antibodies to measles virus in patients with subacute sclerosing panencephalitis or multiple sclerosis.

Authors:  P D Mehta; B A Patrick; W Sobczyk; J Kulczycki; J Woyciechowska-Camenga; D Camenga; H Thormar
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

6.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

7.  On the diagnostic value of different CSF investigations in multiple sclerosis.

Authors:  K Lauer
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

8.  Synthesis of antibodies, including antiviral antibodies, in the knee joints of patients with arthritis.

Authors:  C A Mims; A Stokes; R Grahame
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

9.  Prescribing recommendations for interferon-Beta in multiple sclerosis.

Authors:  B Weinstock-Guttman; R A Rudick
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

Review 10.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.